QQ客服 官方微博 反馈留言

	Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir
	Sun, Jian; Yuan, Quan; Xie, Qing; Fan, Rong; Tan, Deming; Ning, Qin; Niu, Junqi; Bai, Xuefan; Song, Liuwei; Chen, Shijun
刊名	HEPATOLOGY
	2013
卷号	58
ISSN号	0270-9139
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3549082
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Sun, Jian,Yuan, Quan,Xie, Qing,et al. Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir[J]. HEPATOLOGY,2013,58.
APA	Sun, Jian.,Yuan, Quan.,Xie, Qing.,Fan, Rong.,Tan, Deming.,...&Hou, Jinlin.(2013).Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir.HEPATOLOGY,58.
MLA	Sun, Jian,et al."Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir".HEPATOLOGY 58(2013).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。